Gene therapy for hemophilia represents a groundbreaking advancement in treating this inherited bleeding disorder.Historically, individuals with hemophilia, particularly hemophilia B, relied heavily on regular clotting factor therapy to manage their condition and prevent spontaneous bleeding.